Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

biote (BTMD) Receivables: 2021-2025

Historic Receivables for biote (BTMD) over the last 5 years, with Q3 2025 value amounting to $8.0 million.

  • biote's Receivables fell 613.45% to $8.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $8.0 million, marking a year-over-year decrease of 613.45%. This contributed to the annual value of $7.6 million for FY2024, which is 1207.23% up from last year.
  • Per biote's latest filing, its Receivables stood at $8.0 million for Q3 2025, which was down 613.45% from $9.1 million recorded in Q2 2025.
  • In the past 5 years, biote's Receivables registered a high of $10.2 million during Q3 2023, and its lowest value of $5.2 million during Q4 2021.
  • For the 5-year period, biote's Receivables averaged around $7.8 million, with its median value being $7.7 million (2024).
  • Its Receivables has fluctuated over the past 5 years, first skyrocketed by 3329.4% in 2023, then tumbled by 1654.71% in 2024.
  • biote's Receivables (Quarter) stood at $5.2 million in 2021, then skyrocketed by 32.82% to $6.9 million in 2022, then dropped by 2.0% to $6.8 million in 2023, then increased by 12.07% to $7.6 million in 2024, then grew by 4.47% to $8.0 million in 2025.
  • Its last three reported values are $8.0 million in Q3 2025, $9.1 million for Q2 2025, and $7.8 million during Q1 2025.